Hyeon Jeong Lee,Jie Li,Renee E. Vickman,Junjie Li,Rui Liu,Abigail C. Durkes,Bennett D. Elzey,Shuhua Yue,Xiaoqi Liu,Timothy L. Ratliff,Ji-Xin Cheng

Abstract:Supplementary figure S1 shows CE depletion by avasimibe treatment in prostate cancer cells. Supplementary figure S2 shows prostate cancer migration suppressed by ACAT inhibition. Supplementary figure S3 shows suppression of prostate cancer metastasis by targeting cholesterol esterification. Supplementary figure S4 shows expression profiling of prostate cancer-related genes after ACAT inhibition. Supplementary figure S5 shows inactivation of Wnt/beta-catenin pathway by ACAT-1 knockdown. Supplementary figure S6 shows inactivation of Wnt/beta-catenin pathway by cholesteryl ester depletion in multiple prostate cancer cell lines. Supplementary figure S7 shows inactivation of Wnt by ACAT-1 knockdown.

Supplementary Figure 4 from Αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer Through JNK1-Mediated Activation of Androgen Receptor

Supplementary Figure 5 from Αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer Through JNK1-Mediated Activation of Androgen Receptor

Supplementary Figure 8 from Αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer Through JNK1-Mediated Activation of Androgen Receptor

Supplementary Figure 1 from Αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer Through JNK1-Mediated Activation of Androgen Receptor

Supplementary Figures S1 - S7 from Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway

Supplementary Figure 4 from p300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis

Supplementary Figures S1-S6 from Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer Via Its Promotion of Intratumoral Androgen Biosynthesis

Supplementary Figures 1-4 from M<sup>6</sup>a Modification Promotes EMT and Metastasis of Castration-Resistant Prostate Cancer by Upregulating NFIB

Supplementary Figure 6 from p300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis

Supplementary Figures from Abituzumab Targeting of Αv-Class Integrins Inhibits Prostate Cancer Progression

Supplementary Figure 1 from TR4 Nuclear Receptor Alters the Prostate Cancer CD133<sup>+</sup> Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression

Supplementary Figure 3 from p300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis

Supplementary Figure 1 from PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation Via the Activation of Stat3/Bcl-2 Pathway

Supplementary Figures 1-3, Tables 1-3, Table 7, Legends for Figures 1-3, Tables 1-7 from B-Raf Activation Cooperates with PTEN Loss to Drive C-Myc Expression in Advanced Prostate Cancer

Supplementary Figure 5 from p300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis

Supplementary Figure 2 from Chimeric Transcript Generated by Cis-Splicing of Adjacent Genes Regulates Prostate Cancer Cell Proliferation

Supplementary Figure 2 from p300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis

Supplementary Figure 6 from ASC-J9 Suppresses Renal Cell Carcinoma Progression by Targeting an Androgen Receptor–Dependent HIF2α/VEGF Signaling Pathway

Supplementary Figure 2 from Interleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models

Supplemental Figure 1 from Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression

Supplementary Figure 3 from Interleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models